Liu Deguo, Wang Yajian, Yang Xiu-An, Liu Deyun
Department of Paediatrics, The Second Hospital of Anhui Medical UniversityHefei, China.
Joy Orient Translational Medicine Research Center Co., Ltd.Beijing, China.
Front Genet. 2017 Aug 8;8:105. doi: 10.3389/fgene.2017.00105. eCollection 2017.
Silver-Russell syndrome (SRS) is a rare, but well-recognized disease characterized by growth disorder. To date, there are two reports arguing mutation for the onset of SRS. Herein, we present another sporadic case harboring mutation. The male proband was the first and only child of a non-consanguineous Chinese couple. He was small for gestational age, with relative macrocephaly at birth. Severe feeding difficulties, low feeding, and growth retardation were revealed during neonatal period. At 4.5 years old, obvious body asymmetry was noted. Whole exome sequencing identified a novel c.101G > A (p.Gly34Asp, NM_000612) variant in and Sanger sequencing validated the variant. Amplification refractory mutation system polymerase chain reaction demonstrated that the variant was on the paternal allele. Alignment shows the variant is evolutionarily conserved. Structural modeling argues that the variant site might be important for the binding of IGF2 to its receptor. Our study provides further evidence that IGF2 mutation may be another mechanism of SRS, and we consider that IGF2 should be included in a disease specific gene panel in case it is designed for SRS routine diagnostics.
Silver-Russell综合征(SRS)是一种罕见但已被充分认识的以生长发育障碍为特征的疾病。迄今为止,有两份报告认为突变是SRS发病的原因。在此,我们报告另一例携带突变的散发病例。该男性先证者是一对非近亲结婚的中国夫妇的第一个也是唯一的孩子。他出生时孕周小,出生时相对头大。新生儿期出现严重喂养困难、进食少和生长发育迟缓。4.5岁时,发现明显的身体不对称。全外显子测序在[具体基因名称未给出]中鉴定出一个新的c.101G > A(p.Gly34Asp,NM_000612)变异,Sanger测序验证了该变异。扩增阻滞突变系统聚合酶链反应表明该变异位于父本等位基因上。序列比对显示该变异在进化上是保守的。结构建模表明该变异位点可能对IGF2与其受体的结合很重要。我们的研究提供了进一步的证据,表明IGF2突变可能是SRS的另一种发病机制,并且我们认为在为SRS常规诊断设计疾病特异性基因检测板时应纳入IGF2。